title: Diagnosis of amyotrophic lateral sclerosis in a patient treated with TNFalpha blockers for ankylosing spondylitis: fortuitus association or new side effect of TNFalpha blockers?
authors.forename: Valentine
authors.initials: V
authors.lastname: Loustau
authors.forename: Violaine
authors.initials: V
authors.lastname: Foltz
authors.forename: Cécile
authors.initials: C
authors.lastname: Poulain
authors.forename: Sylvie
authors.initials: S
authors.lastname: Rozenberg
authors.forename: Gaëlle
authors.initials: G
authors.lastname: Bruneteau
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis* / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D003711:Demyelinating Diseases / Q000139:chemically induced* / Q000276:immunology; D017809:Fatal Outcome; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D013167:Spondylitis, Ankylosing / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab